AEterna Zentaris Inc (AEZS.O) News|
United States

AEterna Zentaris Inc (AEZS.O)

AEZS.O on Consolidated Issue listed on NASDAQ Capital Market

1 Jul 2016
Change (% chg)

$0.35 (+10.74%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

BRIEF-Aeterna Zentaris, Orient Europharma sign license agreement for Zoptrex

* Aeterna Zentaris and Orient Europharma Co Ltd sign exclusive license agreement for Zoptrex in Taiwan and Southeast Asia

BRIEF-Aeterna zentaris to file a NDA for zoptrex in first half of 2017

* Aeterna Zentaris reconfirms commitment to LHRH-receptor targeting zoptrex during 2016 ASCO annual meeting

BRIEF-Aeterna Zentaris acquires U.S. Promotional rights for prostate cancer blood test

* Aeterna zentaris acquires exclusive u.s. Promotional rights for apifiny prostate cancer blood test Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Select another date: